🟢 Cerenome is trading 6% up in pre-market after in-network agreement expands CNSide access

Cerenome is trading 6.10% up in pre-market at $3.93 after announcing an in-network agreement with Health Care Service Corporation on August 13, 2026.

• The agreement covers approximately 27.3 million additional commercial and Medicare Advantage lives.
• CNSide’s contracted access rises to approximately 153 million, above Cerenome’s 2026 objective ahead of schedule.
• The August 13 earnings release remained anticipated, but no reported results were found before this alert.